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Abstract
Background: Transition from distinct Child and Adolescent Mental Health (CAMHS) to Adult Mental Health Services
(AMHS) is beset with multitude of problems affecting continuity of care for young people with mental health needs.
Transition-related discontinuity of care is a major health, socioeconomic and societal challenge globally. The overall aim
of the Managing the Link and Strengthening Transition from Child to Adult Mental Health Care in Europe (MILESTONE)
project (2014–19) is to improve transition from CAMHS to AMHS in diverse healthcare settings across Europe.
MILESTONE focuses on current service provision in Europe, new transition-related measures, long term outcomes
of young people leaving CAMHS, improving transitional care through ‘managed transition’, ethics of transitioning
and the training of health care professionals.
Methods: Data will be collected via systematic literature reviews, pan-European surveys, and focus groups with
service providers, users and carers, and members of youth advocacy and mental health advocacy groups. A prospective
cohort study will be conducted with a nested cluster randomised controlled trial in eight European Union (EU) countries
(Belgium, Croatia, France, Germany, Ireland, Italy, Netherlands, UK) involving over 1000 CAMHS users, their carers,
and clinicians.
Discussion: Improving transitional care can facilitate not only recovery but also mental health promotion and
mental illness prevention for young people. MILESTONE will provide evidence of the organisational structures and
processes influencing transition at the service interface across differing healthcare models in Europe and longitudinal
outcomes for young people leaving CAMHS, solutions for improving transitional care in a cost-effective manner,
training modules for clinicians, and commissioning and policy guidelines for service providers and policy makers.
Trial registration: “MILESTONE study” registration: ISRCTN ISRCTN83240263 Registered 23 July 2015; ClinicalTrials.gov
NCT03013595 Registered 6 January 2017.
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Background
The journey into adult life is a time of profound physio-
logical, psychological and social change for young people
[1, 2]. Young people are expected to take responsibility
for themselves, make their own decisions and become fi-
nancially independent [3]. Late adolescence is also a high
risk period for the emergence of mental disorders, alco-
hol and substance abuse and risk taking behaviour [1, 4,
5]. Overall rates of mental health problems in young
people increase with age, problems become more com-
plex, and emerging disorders, such as psychosis and per-
sonality disorders, develop [6]. Moreover, mental
disorders in adolescence predict mental health problems
in adulthood [7–9]. 50% of mental health problems
emerge by the age of 16 years and 75% by the age of 24
[10, 11]. Intervening early when mental disorders
emerge, such as in psychosis, can reduce their severity
and persistence and yield positive outcomes [12, 13].
Unsatisfactory care carries a risk of illness extension,
progression and chronicity, which has multiple adverse
effects, including on psychosocial functioning and
self-determination [14, 15]. Yet only a small proportion
of young people with mental health problems, less than
one in six, access services or receive appropriate care
[16–18]. All over Europe, those with persisting mental
health needs usually move from Child and Adolescent
Mental Health Services (CAMHS) to Adult Mental
Health Services (AMHS) around the critical age of 16–
18 years. However, ideological, structural, functional and
organisational differences between CAMHS and AMHS
hamper this transition [19–29]. The disruption of care
to young people at the CAMHS-AMHS interface, and
the long-term adverse effects on their health, wellbeing
and potential is of concern worldwide [1, 8, 30–32].
The importance of improving young people’s transi-
tion from child-orientated to adult-orientated health ser-
vices has been recognised since the early 1990s [33]. For
about a decade, such transition was discussed but rarely
studied [34]. In the 2000s, transitions research in paedi-
atric services increased [35], professional consensus
statements were developed [36, 37] and national policy
recognising the importance of transition started to
emerge [38]. During this decade the importance of youth
mental health [39] and improving transitions between
CAMHS and AMHS started to be highlighted [24, 40,
41]. Research on transition experiences of young people
with mental health problems started to be published,
from sources in the USA in the early 2000 (e.g. [42, 43])
and later in the decade from the United Kingdom (UK)
[44]. The transitions of care from child and adolescent
mental health services to adult mental health services
(TRACK) study [28, 29] and other research show that
many young people with established mental health prob-
lems, such as neurodevelopmental and conduct
disorders and those with emerging mood, psychotic,
personality-related or substance abuse disorders slip
through the care net at the transition boundary [29,
45–48]. With insufficient support in place, many disen-
gage from mental health services altogether only to
present to adult services subsequently, with more severe
and enduring mental health problems [24, 49, 50]. Such
occurrences may have been prevented or better con-
trolled had better transition arrangements been in place.
Young people who undergo a planned and purposeful
transition process that addresses their psychosocial and
medical needs, experience an improvement in their
mental health and functioning [29, 47]. Yet, due to a
policy-practice gap [28], few of those who do transition
from CAMHS to AMHS experience ‘optimal transition’,
which has been characterised by a period of parallel care
between CAMHS and AMHS, at least one transition
planning meeting, adequate information transfer and
continuity of care [27]. Studies carried out in the Repub-
lic of Ireland [23, 51] and France [52] suggest that prob-
lems of the same nature and magnitude at the
CAMHS-AMHS interface are occurring in other
European countries. This poses a major health, socioeco-
nomic and societal challenge for the care and wellbeing
of young people with mental health needs within the
European Union (EU), which is exacerbated by the dif-
ferent mental health care service structures and
provision in the member states [53–55]. The develop-
ment of solutions is made harder by the lack of system-
atic and robust evidence on the nature and severity of
transition-related problems across the differing health
care contexts in Europe and on their impact upon the
health and wellbeing of young people.
The transitions literature often uses words such as
‘lost’ [56, 57], ‘divide’ [41] and ‘gap’ [51] to describe what
happens to young people or the care of young people at
the CAMHS-AMHS interface. Different models of tran-
sitional mental health care for young people have been
developed to maintain continuity of care, but recent sys-
tematic reviews show few adequately powered studies,
randomised controlled trials or case-controlled studies
evaluating their effectiveness [19, 58, 59]. The protocol
and reciprocal agreement model of transitional care,
prevalent in the United Kingdom, suffers from a policy–
practice disconnection [29] and organisational differ-
ences between CAMHS and AMHS [22, 60]; transition
programme models, more prevalent in the United States,
tend to be difficult to roll out state-wide and have not
been attempted nation-wide [61–63]. No studies have
evaluated the shared management framework model
[57]. It is also not clear how much of the published re-
search was informed by patient and public involvement
at the design stage, rather than research studying the
views of service users and their parents/carers. The
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quality of research into the ethical aspects of mental
health transitions is poor in general [58] and the ethics
of assuming transition to adult services is the ideal has
been questioned by reviewers of papers and researchers
because of possible risks associated with pathologising
transient and self-limiting distress and dysfunction,
which may be normal during adolescence.
The five year (2014–19) European Union-funded
Managing the Link and Strengthening Transition from
Child to Adult Mental Health Care (MILESTONE) pro-
ject (grant number 602442) will create a rich evidence
base on transitional mental health care in Europe. Work
is subdivided into several high-quality work packages fo-
cusing on different key aspects of research, bringing to-
gether a European consortium of researchers.
Objectives of MILESTONE
The overall aim of MILESTONE is to study transition
from CAMHS to AMHS within the EU and to
strengthen transitional care across different healthcare
systems. The key strategic objectives are to:
1. Delineate the CAMHS-AMHS interface across all
EU nation states in terms of transition of care,
service organisation, legal and policy imperatives,
professional training and user/carer experience.
2. Understand the processes, outcomes and
experiences of transition from CAMHS to AMHS
in healthcare settings across eight countries
(Belgium, Croata, France, Germany, Ireland, Italy,
the Netherlands, and the UK) in the EU, using a
bespoke suite of measures and to develop an ethical
framework for providing appropriate care to
adolescents as they move to adulthood.
3. Robustly test a model of ‘managed transition’ for its
clinical and cost-effectiveness in improving health
and social outcomes and transition to adult health
services, as compared to treatment as usual.
4. Disseminate this evidence by developing training
modules for clinicians, and commissioning and
policy guidelines for service providers and policy
makers; and extending knowledge about transition
to mental health professionals, to service users and
their families, and to society in general.
MILESTONE research
MILESTONE comprises seven freestanding research
projects, which are organised into work packages (WP)
(see Additional file 1):
i) mapping the CAMHS-AMHS interface and
transition in all EU states via surveys (WP1);
ii) developing two measures, the Transition Readiness
and Appropriateness Measure (TRAM) and the
Transition Related Outcome Measure (TROM), to
aid clinicians’ decision-making and stimulate shared
decision-making together with young people and
their parents (WP2);
iii) tracking the journey and outcomes of young people
as they move out of CAMHS in a prospective
cohort study in the eight MILESTONE countries*
(WP3);
iv) assessing the effectiveness of a ‘managed transition’
model based on the TRAM in a nested cluster
randomised controlled trial (cRCT) within the
prospective cohort* (WP4);
v) determining the cost-effectiveness of the model of
‘managed transition’* (WP5);
vi) exploring ethical aspects of transitional care via
qualitative and quantitative methods (WP6);
vii) understanding and further developing professional
and clinical training models in CAMHS and AMHS
addressing service transition via a systematic review
and surveys (WP8).
*Together, these work packages constitute the
“MILESTONE study”.
The main deliverables for the EU for each work pack-
age are listed in Additional file 2.
Overview and geographical reach of the research projects
carried out within MILESTONE are illustrated in Fig. 1.
Methods/design
WP 1: Mapping the CAMHS-AMHS interface across
European mental health services
The aim of this work package is to analyse the clinical,
organisational and legal aspects of CAMHS-AMHS
interface at national and regional levels across all 28
EU states. The mapping exercise will help identify tran-
sition policies and models in different EU healthcare
and social settings, and clarify how and by whom deci-
sions about transition are made within each national
mental health system. A futher aim is to examine tran-
sition in other health areas and social services in the
different European countries.
A list of European governmental and non-governmental
associations able to provide data on CAMHS/AMHS
interface and transition was collated. Two measures
were developed in English for completion online via a
dedicated web domain by country experts – child
psychiatrists and representatives of national child-
psychiatry associations – within each of the 28 EU
member states: 1) the European CAMHS Mapping
Questionnaire (ECM-Q), which was based on the
European Service Mapping Schedule [64] and inte-
grated many of the domains used WHO CAMHS Atlas
[65]; and 2) the Standardized Assessment Tool for
Mental Health Transition (SATMEHT), which was
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developed from an instrument used in the TRACK
study [29] and other questionnaires [34, 43, 66, 67].
For the ECM-Q, the primary aim was to characterise
child and adolescent mental health care provision across
countries (e.g. number of CAMHS per 100,000 young
people), including collaboration with other services, ac-
tivity data and funding sources. For the SATMEHT, the
primary aim was to characterise the transition process
and services configuration per country (e.g. proportion
of young people attending CAMHS needing a transition
to AMHS), including the availability of policies regulat-
ing the CAMHS-AMHS interface and the degree of
stakeholders’ involvement. More detailed methodology
and findings from the ECM-Q and SATMEHT have
been reported elsewhere [68, 69].
WP 2: Development and monitoring using the MILESTONE
suite of measures
Ideally all young people who reach the CAMHS-AMHS
transition boundary should be assessed in a structured
and standardised way to determine ongoing need for
care [32]. Feeding back structured assessment results to
clinicians can lead to improved clinical decision making
[70]. Clinical judgements made under time and resource
constraints are affected by diagnostic and cognitive
biases, assumptions based on patient background, a
disregard of conflicting information, and misperceptions
of other/adult services [70, 71]. So far a planned, pur-
poseful and needs-based assessment of those who reach
the transition boundary does not exist. Furthermore,
there are no validated and reliable measures that specif-
ically assess the experience, outcomes, and effectiveness
of mental health transitional care.
The aim of this work package was therefore to create a
low-burden, reliable and efficient suite of measures re-
lated to transitioning from CAMHS to AMHS, one for
assessing the young person’s readiness and appropriate-
ness for transition, and the other for measuring out-
comes linked with transition. The Transition Readiness
and Appropriateness Measure (TRAM) is a clinician
support and assessment tool designed to identify
high-risk, high-need young people for whom transition
to AMHS is critical. The Transition Related Outcome
Measure (TROM) assesses the quality and outcome of
transition, and includes most domains present in the
TRAM, allowing for comparison of results over time.
Most questions in the TRAM and TROM are asked of
all respondent types (young person, parent/carer and
clinician); some are relevant only to the clinician and
others only to the young person and parent/carer. The
TRAM forms the basis of ‘managed transition’, as de-
scribed below.
Fig. 1 Research projects within MILESTONE. Green hexagons: research involving the eight MILESTONE countries only. Grey hexagons: research
involving all European countries
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TRAM and TROM were developed using qualitative
and quantitative methods following the US FDA
Guidance for Patient-reported Outcome Measures [72].
Literature was critically reviewed for item/concept iden-
tification, and three waves of focus groups on item/con-
cept elicitation were carried out involving young people
with experience of CAMHS, their parents/carers and
mental health professionals at two mental health NHS
trusts in the UK. Based on the analysis of the data thus
obtained, items were formed into scales and subjected to
user testing so that problems with the format and com-
pletion issues could be identified. The final versions
were translated into French, Italian, German, Dutch and
Croatian. Participant-optimised web-based versions were
developed using HealthTracker™ (https://www.health-
tracker.co.uk/), a web-based portal which allows mea-
sures to be completed remotely and which has been
used in other EU FP7 projects [73]. The construct valid-
ity, content validity, inter-rater reliability, test-retest reli-
ability, and sensitivity to change of TRAM and TROM
were assessed in a sub-study conducted in the eight
MILESTONE countries, involving young people with ex-
perience of CAMHS, parents/carers/spouses, and mental
health professionals. The development, psychometric
testing and implementation of TRAM and TROM will
be presented in separate publications.
The “TRAM score summary report” brings together
the TRAM scores from the young person, parent/carer
and CAMHS clinician with graphs visualising differences
or similarities in responses. The report, which is de-
signed as a decision support tool, contains items that are
relevant to clinicians’ transition decisions (symptoms,
risk factors and disruption experienced by the young
person) and those that can facilitate a smooth transition.
It is intended as a quick and efficient method of display-
ing all information relevant to transition decisions in a
user-friendly, relevant and accessible format, allowing
key facts to be easily transferred to care plans and refer-
rals. The report forms the basis of ‘managed transition’
and its ease of use will be verified by questioning clini-
cians partaking in the MILESTONE study (see below).
WP 3 & 4: The MILESTONE study: A longitudinal cohort
study of transition of care from CAMHS to AMHS and a
nested cluster randomised control trial (cRCT) of managed
transition in improving outcomes for young people
We do not know the longitudinal outcomes and experi-
ences of young people who reach the transition bound-
ary for CAMHS in different EU countries, with varying
service structures, transition ages, service provision and
care. Furthermore, despite the intuitive simplicity and
clinical importance of a care pathway which incorporates
an evidence-based decision-making process for
identifying those with on-going care need, a transition
model including such an approach is not available,
although its need has been articulated [74, 75].
We developed the ‘MILESTONE study’ to capture
this missing information [76]. In this ongoing study we
recruit and prospectively follow a large cohort of over
1000 young people approaching the CAMHS-AMHS
transition boundary in the participating EU countries.
The cohort study aims to evaluate the young people’s
mental health, quality of life and functioning while still
at CAMHS, and identify predictors of transitional tra-
jectories, experiences and mental health outcomes over
a follow-up period of two years. Nested within this co-
hort study is a cluster randomised controlled trial
(cRCT) testing whether the implementation of the
model of managed transition in CAMHS at the transi-
tion boundary improves the mental health and social
outcomes of young people and their transition to adult
roles when they move on from CAMHS, as compared
with usual care. ‘Managed transition’ includes feedback
to clinicians from the TRAM assessment. In the inter-
vention arm clusters, clinicians are provided with
TRAM Score summary reports for the young people
participating in the study. Clinicians are advised to dis-
cuss the report with the young person and parent/carer,
include relevant points in a transitional care plan, and
to attach it to the referral letter, if further care is indi-
cated. Young people in the control clusters receive
treatment as usual, which depends on service and may
or may not include transition planning.
The cohort study and cRCT share recruitment and
data collection. Detailed information about eligibility
criteria and methodology have been described else-
where [76]. The primary outcome for the trial is mental
health and social functioning status as measured by the
Health of the Nation Outcome Scale for Child and
Adolescents (HoNOSCA) at 15 months after baseline
[77–79]. The measure is completed by a trained MILE-
STONE research assistant by interviewing the young
person and taking into account all other available
sources of information (parent/carer, relevant clinician
and the medical records) to ensure accuracy of data
[80]. The secondary outcomes are detailed in the study
protocol, and include transition outcomes (TROM),
self-reported and parent/carer reported psychopathology,
emotional and behaviour problems of the service user
(reported by both parent/carer and the young person him/
herself ), illness severity, quality of life, independent
behaviour, illness perception, barriers to care, transi-
tion experience and readiness, and adult functioning
[76]. Data collection is the same in the intervention
and control clusters. Outcomes are measured
9 months (T2), 15 months (T3) and 24 months (T4)
after baseline (T1).
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WP 5: Economic evaluation of the ‘managed transition’
intervention
This work package evaluates the cost-effectiveness of the
model of ‘managed transition’. The aim is to assess
whether the intervention conveys any benefits regarding
participant health-related quality of life and HoNOSCA
scores, as well as health care usage, social care usage/so-
cial costs and intervention costs as compared to treat-
ment as usual. Data collection is embedded in the
MILESTONE study [76].
Quality adjusted life years (QALYs) and HoNOSCA
score are the two primary outcomes for the economic
evaluation [77, 78]. The EQ-5D-5L [81] will be used to
measure Health-related quality of life (HRQL). Young
people in the MILESTONE study compete the measure
at all four time points. Index scores [82] will be applied
to calculate QALYs to ascertain the impact of the inter-
vention on HRQL. The cost-effectiveness of the inter-
vention on mental health will be estimated by examining
changes in QALYs and HONOSCA score between the
two trial arms in conjunction with the costs. The influ-
ence of alternative service delivery models and national
settings on cost-effectiveness will be explored.
Health and social care resource utilisation is the sec-
ondary outcome. The MILESTONE specific Client Ser-
vice Receipt Inventory (CSRI) completed at the four
time points has been designed to help estimate the util-
isation of resources. It draws on a CSRI used previously
to estimate mental health care costs in the UK [83], but
was substantially revised for use in MILESTONE. Fur-
thermore, CAMHS/AMHS in intervention sites are
asked for specific details of the impact of the ‘managed
transition’ intervention in terms of the number of staff
involved in transition, their workload, and additional ser-
vice resources required.
WP 6: Ethics of transitioning
An enquiring ethical stance is needed in the face of an
automatic assumption that transfer of care from child to
adult services is necessarily ‘good’ or appropriate in all
cases [84–86]. Yet there is very little research on ethical
aspects of transitional care.
The aim of this work package is therefore to a) scrutin-
ise the assumption that transition from CAMHS to
AMHS is always the best option, and b) explore the eth-
ical/legal challenges of ensuring delivery of transitional
care to those who need it most against the risk of patholo-
gising transient and self-limiting distress and dysfunction,
which may be normal during adolescence. The work pack-
age has three main parts to it: a systematic review, a focus
groups with members of youth advocacy and mental
health advocacy groups, and focus groups with partici-
pants of the MILESTONE study with different transition
experiences. The first two parts contribute to the develop-
ment of an Ethics of Transitioning questionnaire.
The systematic review focuses on ethical aspects of tran-
sitional care between child-orientated and adult-orientated
health services in general; a more detailed methodology
and findings have been reported elsewhere [87].
The focus groups with members of youth advocacy
and mental health advocacy groups were carried out in
the Republic of Ireland, the UK and Croatia by address-
ing ethical issues raised in vignettes. Each vignette de-
scribed a young person with a particular diagnosis and
mental health history approaching the end of their care
at CAMHS, with a decision needed to be made regard-
ing their onward mental health treatment. The Ethics of
Transitioning questionnaire developed based on the
findings of the focus groups and systematic review was
included in the assessment battery of the MILESTONE
study to retrieve young people’s views about ethical as-
pects of transitioning from all eight countries.
The focus groups with young people and parents/
carers who have participated in the MILESTONE study
will be conducted during the last assessment time point
of the MILESTONE study in at least the three above
countries. The aim will be to explore the actual experi-
ences of the young people regarding services at the tran-
sition boundary, but also their views regarding the
ethical aspects of service provision. Separate focus
groups with a maximum of five participants will be held
for young people and parent/carers, with a total of ap-
proximately 20 young people and 10 parent/carers tak-
ing part per country.
Data from the separate arms of the ethics work pack-
age will be integrated during the analysis phase, and
linked up with findings from the MILESTONE study.
WP 8: Training of professionals for improving transitional
care across the EU
Many of the profound clinical, conceptual and ideo-
logical differences between child and adult mental health
service models that contribute to transitional problems
are related to psychiatry and other associated profes-
sional training. For example, the CAMHS-AMHS separ-
ation and consistent differences in care philosophies has
allowed clinical focus to shift away from developmental
psychiatry [19].
The aims of this work pachage are to describe current
training models used across EU for CAMHS and AMHS
and to assess their contribution and impact on the or-
ganisation and efficacy of transitional care at the service
provider level. This will be achieved by conducting a) a
systematic review on adult and child/adolescent psych-
iatry training and b) surveys on psychiatry and psych-
ology training. We will also develop training models and
guidelines for universities and policy makers according
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to the results of the studies in MILESTONE in order to
optimize transition between child and adult mental
health services.
The systematic review focuses on two key themes: 1)
the structure and content of current training across
Europe in general and adult psychiatry (GAP) and child
and adolescent psychiatry (CAP) as defined by the
European Union of Medical Specialists (UEMS) [88]; and
2) if and how transition is addressed in any of the GAP and
CAP training. The review covers all European countries.
Bespoke questionnaires have been developed for the
surveys: The psychiatry questionnaire covers adult
psychiatry and child and adolescent psychiartry training
in Europe, with questions for both specialties on theoret-
ical and practical training, and transition as a subject.
The questionnaire is aimed at representatives in charge
of specialized training in psychiatry in all EU-countries.
A similar questionnaire on psychology training aimed at
representatives of national psychological associations in
the eight MILESTONE countries has also been devel-
oped and circulated. A third survey focuses on trainees’
perspectives and is conducted in collaboration with the
European Federation of Psychiatric Trainees.
In the analysis phase, findings will be compared and
integrated with the other studies running under the
MILESTONE project, for the development of a) a training
programme for transitional care and b) guidelines for har-
monizing CAMHS and AMHS training across the EU.
Governance, oversight committees and patient and public
involvement (PPI)
The MILESTONE consortium is a partnership between
academics and clinicians from child and adult psychiatry
and psychology, researchers, voluntary services and advo-
cacy groups in eight countries. Management is through a
monthly steering committee (SC, i.e. trial management
group), comprising principal investigators from each
MILESTONE country and core research staff. Practical-
ities of the MILESTONE study are discussed at regular re-
search assistant (RA) teleconferences. The SC meets
face-to-face every six months, and the whole research
team annually (General Assembly). Project management
is provided by concentris, a small and medium-sized en-
terprise specialised in the management of EU-funded pro-
jects. The conduct and progress of MILESTONE as a
whole is overseen by the independent MILESTONE
Scientific, Clinical and Ethical Advisory Board (SCEAB). It
meets annually at the General Assembly and comprises
four international experts and four Patient and Public
Involvement (PPI) representatives who offer advice
and monitor the progress of the project towards its
stated aims.
MILESTONE has strong PPI embedded throughout
the project. Initially, five British service user
representatives were identified, engaged, and appropri-
ately trained and supported to participate in the project
as consultants and steering group members. They have
provided advice on the development and refinement of
the research methodology of the MILESTONE study,
tested the suite of study documents, and recommended
strategies for recruitment and retention of participants.
They also assist the various other research projects run-
ning under MILESTONE, attend the SC and annual
general meetings, and help plan and develop public en-
gagement activities. In the last two years, young service
users from another MILESTONE country, and carer
representatives, will be involved. The ongoing work of
the PPI representatives was recognised in the UK by a
service user and carer involvement in mental health re-
search award in 2016.
Dissemination
Effective and creative dissemination of the MILESTONE
project will be ensured throughout all its stages, from in-
ception and recruitment to study results and recommen-
dations to all stakeholders, including service providers,
commissioners, policy makers, user and carer groups and
any other target groups working at the interface between
adolescence and adult mental health care. To date, this in-
cludes a TEDx talk and a film on the theme of transition
developed through participatory workshops involving
MILESTONE PPI representatives and researchers.
Discussion
The MILESTONE project is to the best of our know-
ledge the first of its kind in the scope and scale of re-
search focused specifically on transitions at the
CAMHS-AMHS interface across Europe. It will provide
a comprehensive yet nuanced account of the organisa-
tion, policy, and practice of care for young people with
mental health needs at the CAMHS-AMHS boundary
across the EU, and a timely analysis of their outcomes
and experiences. This will help identify opportunities to
improve their health care outcomes, social functioning,
and quality of life, enabling them to more easily progress
to meaningful adult roles.
Although there are some existing service level innovations
in Australia (ORYGEN, Melbourne https://oyh.org.au/),
Ireland (JIGSAW, https://www.jigsaw.ie/) and UK (Forward
Thinking Birmingham, https://www.forwardthinkingbirmin
gham.org.uk/) that are attempting, in their different
healthcare contexts, to redefine service structures for
young people with mental health needs (up to 25 years),
there is still much to be done. The practice of having a
CAMHS-AMHS divide is deeply rooted in European
mental health provision and tradition. First politically
relevant steps are being taken in some countries. In
Germany, for example, national specialist societies are
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identifying the need for interdisciplinary cooperation
and a “Transitional Psychiatry Task Force” has been
created. It is expected that the findings of MILESTONE
will encourage services across Europe to question their
structure and identify current weaknesses in the
CAMHS-AMHS care pathway so that outcomes for
young people and their families can be improved by
adapting best evidence-based practice into their service
provision. Proposed changes to services should ensure
that those young people who need it receive on-going
care and that others with transient or remitted condi-
tions are not ‘pathologised’ and do not receive inappro-
priate, unnecessary or potential harmful interventions.
Although structural weaknesses at the CAMHS-AMHS
interface have been recognised for almost 25 years [33],
the evidence base is still weak and the need for high
quality research and common efforts at different levels
(across countries, involving various research organisa-
tions, professional bodies and specialist societies) re-
mains high. Action is needed to bring together the
seemingly disparate worlds of child/adolescent and
adult mental health services and learn from other coun-
tries about how to minimise policy-practice gaps, and
improve transition procedures and outcomes. Any re-
search should be informed by and involve young people
who have experienced transition from CAMHS [89].
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